Current location - Recipe Complete Network - Complete breakfast recipes - Does Piperazine Phosphate Botulinum Sugar have side effects?
Does Piperazine Phosphate Botulinum Sugar have side effects?
Piperazine Phosphate Botulinum Sugar has no significant toxic side effects, (adverse reactions). However, if the patient's side effects of Piperazine Phosphate are significant, the patient must consult a doctor immediately, so that the doctor can diagnose and prescribe the right medicine in a timely manner.

Piperazine phosphate Baotao sugar generic name for piperazine phosphate Baotao sugar, trade name is piperazine phosphate Baotao sugar, this product is a colorful tower-shaped sugar ingots. It is used for children's roundworm and pinworm infections. So does Piperazine Phosphate Potassium Glucose have side effects?

Side effects are pharmacological effects other than those intended for therapeutic purposes that occur after the application of a therapeutic amount of the drug. Positive drug effects are the main ones. A drug often has multiple effects, both therapeutic and non-therapeutic.

Side effects and therapeutic effects can be transformed under certain conditions, and the difference in therapeutic purpose also leads to a conceptual shift in side effects. Side effects are often transient and disappear with the disappearance of the therapeutic effect. But sometimes they can also cause sequelae.

Pharmaceuticals are like a double-edged sword, in the therapeutic effect at the same time, there are bound to be adverse reactions. Therefore, the notification of adverse reactions to drugs does not indicate that the drugs are substandard, and should not be compared with "poison", "fake drugs", "bad drugs", "can not be used". At present, Guangdong Province has launched an adverse drug reaction reporting system, Chen Tai-chang said, reporting adverse drug reaction events is to remind drug manufacturers, operating companies, medical institutions and the general public attention to the existence of drug safety hazards, and try to avoid the recurrence of serious adverse drug reactions, so as to safeguard the public safety of medicines to build an effective barrier.